Sigrid Lundberg

Danderyd, AB, Sweden

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Smoldering Segmental Sclerosis: A Potential Guide to Therapy in IgA Nephropathy.

Smoldering Segmental Sclerosis: A Potential Guide to Therapy in IgA Nephropathy.

Journal: Journal of the American Society of Nephrology : JASN

Published: January 21, 2026

Broccoli Sprout Extract for Glycemic Management in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Trial.

Broccoli Sprout Extract for Glycemic Management in Patients with Chronic Kidney Disease and Type 2 Diabetes: A Randomized Double-Blind Placebo-Controlled Trial.

Journal: Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation

Published: September 14, 2025

Primary glomerular diseases and long-term adverse health outcomes: A nationwide cohort study.

Primary glomerular diseases and long-term adverse health outcomes: A nationwide cohort study.

Journal: Journal of internal medicine

Published: November 13, 2024

Genome-wide studies define new genetic mechanisms of IgA vasculitis.

Genome-wide studies define new genetic mechanisms of IgA vasculitis.

Journal: medRxiv : the preprint server for health sciences

Published: October 17, 2024

Exercise limitation in chronic kidney disease: An experimental pilot study with leg and arm exercise.

Exercise limitation in chronic kidney disease: An experimental pilot study with leg and arm exercise.

Journal: Physiological reports

Published: September 17, 2024

Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity.

Urine complement-related proteins in IgA nephropathy and IgA vasculitis nephritis, possible biomarkers of disease activity.

Journal: Clinical kidney journal

Published: May 10, 2024

Albuminuria predicts kidney events in IgA nephropathy.

Albuminuria predicts kidney events in IgA nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: January 06, 2024

We can go further in non-immunosuppressive treatment of IgA nephropathy.

We can go further in non-immunosuppressive treatment of IgA nephropathy.

Journal: Lancet (London, England)

Published: March 20, 2023

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy.

Journal: Nature genetics

Published: December 06, 2021

Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis.

Long-Term Outcomes of Patients with IgA Nephropathy Categorized by the International IgAN Risk Prediction Tool and by the Degree of Hematuria at Diagnosis.

Journal: Nephron

Published: November 18, 2021

B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.

B cell and monocyte phenotyping: A quick asset to investigate the immune status in patients with IgA nephropathy.

Journal: PloS one

Published: November 16, 2020

Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study.

Immunoglobulin A nephropathy and ischemic heart disease: a nationwide population-based cohort study.

Journal: BMC nephrology

Published: October 15, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026